secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001193805-23-000861
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus Therapeutics stockholders elect eight directors, approve say-on-pay and auditor ratification at annual meeting
--------------------------------------------------------------------------------

- All eight director nominees elected; Dr. Magda Marquet received lowest approval with 66.7% of votes for.
- Non-binding advisory say-on-pay resolution approved with 11,959,501 votes for (72.4%) vs 4,562,055 against.
- Ratification of Ernst & Young as auditor for FY2023 approved with 18,955,484 votes for, only 22,224 against.
- Quorum established with 18,987,002 shares represented (71.5% of outstanding 26,562,951 shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380523000861/0001193805-23-000861-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380523000861/e618703_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-23-000861

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer